CVS Health price target raised to $113 from $107 at RBC Capital
RBC Capital raised the firm's price target on CVS Health to $113 from $107 and keeps an Outperform rating on the shares as part of a broader research note previewing Q2 earnings in Healthcare Services and Managed Care. The firm is expecting payor strength seen since April to sustain amid growing concern over volume and